Creating a healthier Singapore with digital solutions: Q&A with Glenn Neo

G.NeoG.Neo
K.YuK.Yu
BulletArticle
Leaders In Conversation Artificial Intelligence Digital Transformation Population Health Management
共享以下内容：
复制链接

In this insightful interview, Karen Yu, Country Manager for Roche Diagnostics Singapore, sits down with Glenn Neo, Director of Innovation and Capabilities Enablement (ICE) at Synapxe, the national HealthTech agency of Singapore, for a wide-ranging conversation. Together, they explore the vital role of technology in enhancing healthcare services in Singapore, the potential of generative AI, and how the agency is working towards inspiring tomorrow’s health through innovation and collaboration. 

共享以下内容：
复制链接

有关同一主题的更多信息

Growing one of Indonesia’s largest laboratory chains: Q&A with Dr Dewi Muliaty 

Dr William Morice II’s visions and considerations for building a global diagnostics ecosystem

推荐主题

SequencingRED 2020Rare Diseases
下次阅读
  • Artificial Intelligence, Digital Transformation, Leaders In Conversation, Management, Operations, Population Health Management
Creating a healthier Singapore with digital solutions: Q&A with Glenn Neo
How Awanui Group drives diagnostic excellence in New Zealand: Q&A with Anoop Singh (Part 1)
  • C-Suite Perspectives, Leaders In Conversation, Management
Awanui Group’s quest to improve lab diagnostics in New Zealand: Q&A with Anoop Singh (Part 1)
‘Real world evidence’ and clinical labs: a brief introduction
  • Healthcare Transformation, Management, Operations, Population Health Management
‘Real world evidence’ and clinical labs: a brief introduction
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
  • Disease Area, Healthcare Transformation, Histopathology, Leaders In Conversation, Management, Oncology, Operations
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
Scroll to Top